09:41 EST Tempest Therpeutics trading halted, volatility trading pause
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TPST:
- Tempest announces acquisition of new dual-CAR T programs from Factor Bioscience
- Tempest Therapeutics Reports Q3 2025 Financial Results
- Tempest Therapeutics reports Q3 EPS (79c) vs ($5.32) last year
- TPST Earnings this Week: How Will it Perform?
- Tempest Therapeutics and Adagene’s Promising Advances in Liver Cancer Treatment